|
Match
|
Document |
Document Title |
|
|
7419696 |
Medical devices for delivering a therapeutic agent and method of preparation
A method for making an intravascular stent by applying to the body of a stent a solution which includes a solvent, a polymer dissolved in the solvent and a therapeutic substance dispersed in the...
|
|
|
EP1795196A2 |
Method of treating lower urinary tract disorders
The invention relates to the treatment of at least one symptom of a lower urinary tract disorder in a subject in need of treatment wherein the symptom is selected from the group consisting of...
|
|
|
EP1721607A1 |
Methods for treating lower urinary tract disorders using smooth muscle modulators and alpha-2-delta subunit calcium channel modulators
A method is provided for using α 2 δ subunit calcium channel modulators or other compounds that interact with the α 2 δ calcium channel subunit in combination with one or more compounds with...
|
|
|
7105571 |
Prostaglandin compositions and methods of treatment for male erectile dysfunction
The invention provides methods and compositions for treating erectile dysfunction. The methods include the step of placing within the fossa navicularis of the patient an effective erection-inducing...
|
|
|
7087240 |
Device and method for the treatment of erectile dysfunction
Devices and methods for treatment of erectile dysfunction and methods of manufacture and of use are provided. The devices include filmogenic material, a therapeutic agent, a permeation enhancer,...
|
|
|
6897239 |
Use of misoprostol and/or metabolites of misoprostol for treating sexual dysfunction in women
Topical application of a prostaglandin directly to the clitoris is effective for enhancing female sexual desire and responsiveness.
|
|
|
6825234 |
Compositions and methods for amelioration of human female sexual dysfunction
The invention provides compositions and methods suitable for ameliorating female sexual dysfunction, and in particular, female sexual arousal disorder. In one embodiment, the invention provides a...
|
|
|
6756407 |
Method and compositions for the treatment or amelioration of female sexual dysfunction
The present invention provide a method of treating sexual dysfunction in a female, including the vasculogenic symptoms of delayed vaginal engorgement, diminished vaginal lubrication, pain or...
|
|
|
6693135 |
Prostaglandin compositions and methods of treatment for male erectile dysfunction
The invention provides methods of treating erectile dysfunction comprising the step of placing within the fossa navicularis of the patient an effective erection-inducing amount of a prostaglandin E...
|
|
|
6627663 |
Noninvasive method for treating hemangiomas through transdermal delivery of calcium channel blocker agents and medicament for use in such method
The invention is of a noninvasive method for treating hemangiomas involving the topical application of verapamil suspended in a carrier through which penetration of verapamil is enhanced.
|
|
|
6593369 |
Methods, compositions, and kits for enhancing female sexual desire and responsiveness
Topical application of a prostaglandin directly to the clitoris is effective for enhancing female sexual desire and responsiveness.
|
|
|
6589990 |
Methods and compositions for misoprostol compound treatment of erectile dysfunction
Therapeutic formulations and methods for treating erectile dysfunction with a misoprostol compound in a subject are provided, a method comprising: obtaining a therapeutic formulation having an...
|
|
|
6559184 |
Methods and compositions for treating male erectile dysfunction
Administration of a pharmaceutical composition in the form of a suppository comprising: (a) a prostaglandin vasodilator; (b) 15-hydroxyprostaglandindehydrogenase inhibitor: and (c) a base material...
|
|
|
6548490 |
Transmucosal administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction
A method is provided for treating erectile dysfunction in a mammalian male individual. The method involves the transmucosal administration of a phosphodiesterase inhibitor or a pharmaceutically...
|
|
|
6525100 |
Composition and method for treating peyronie's disease and related fibrotic tissue disorders
The invention is of a topical medicament and associated methodology for use thereof, through the use of which Peyronie's disease may be effectively, cost effectively, and painlessly treated. The...
|
|
|
6486207 |
Compositions and methods for amelioration of human female sexual dysfunction
The invention provides a composition suitable for topical application comprising: an effective amount of a prostaglandin, a polymer thickener, a lipophilic component, and a buffer system. In...
|
|
|
6479000 |
Urethral urine retention device
An apparatus for sealing at least a portion of the urinary tract to prevent the unwanted discharge of urine includes a body member with a tubular member, encircled along its length by an overcoat...
|
|
|
6414027 |
Methods and compositions for treating male erectile dysfunction
Administration of a pharmaceutical composition in the form of a suppository comprising: (a) a prostaglandin vasodilator; (b) 15-hydroxyprostaglandindehydrogenase inhibitor; and (c) a base material...
|
|
|
6410595 |
Methods and compositions for treating male erectile dysfunction
Administration of a pharmaceutical composition comprising: (a) a vasodilator; and (b) a 15-hydroxyprostaglandindehydrogenase inhibitor is effective for the treatment of male erectile dysfunction.
|
|
|
6403605 |
Methods for the normalization of sexual response and amelioration of long term genital tissue degradation
The present invention provides, in one embodiment, a method of normalizing the timing of sexual response in a mammal comprising the administration of an amount of a central nervous system sexual...
|
|
|
6395744 |
Method and compositions for the treatment or amelioration of female sexual dysfunction
The present invention provide a method of treating sexual dysfunction in a female, including the vasculogenic symptoms of delayed vaginal engorgement, diminished vaginal lubrication, pain or...
|
|
|
6365590 |
Compounds, compositions and methods for treating erectile dysfunction
Vasoactive compounds are described for the treatment of erectile dysfunction and impotence. The compounds are reaction products of an anionic or negatively charged vasoactive or erection-inducing...
|
|
|
6353028 |
Composition and method for topically treating Peyronie's Disease, Dupuytren's hand contracture, Ledderhose Fibrosis, erectile dysfunction arising from plaque accumulations, and scarring
The invention is of a topical medicament and associated methodology for use thereof, through the use of which fibrotic or connective tissue disorders involving scarring, sub-dermal plaque...
|
|
|
6323241 |
Prostaglandin compositions and methods of treatment for male erectile dysfunction
The invention provides methods of treating erectile dysfunction comprising the step of placing within the fossa navicularis of the patient an effective erection-inducing amount of a prostaglandin E...
|
|
|
6315711 |
Urethral urine retention device
An apparatus for sealing at least a portion of the urinary tract to prevent the unwanted discharge of urine includes a body member with a tubular member, encircled along its length by an overcoat...
|
|
|
6306437 |
Apomorphine-containing dosage forms for ameliorating male erectile dysfunction
Psychogenic impotence can be ameliorated without substantial undesirable side effects by administration of apomorphine and an antiemetic agent in an amount sufficient to substantially reduce nausea...
|
|
|
6291528 |
Prostaglandin E1/F2 in combination with prostaglandin F2α for enhancing female sexual arousal
A method of treating and a composition for treating female sexual arousal dysfunction, comprising administering to the patient a unit dose of a formulation comprising an effective amount of a...
|
|
|
6290981 |
Use of nitric oxide-releasing agents to treat impotency
A method of treatment for impotency is provided. The method involves the administration of nitric oxide by a nitric oxide-releasing agent capable of providing a penile erection-inducing amount of...
|
|
|
6284262 |
Compact dosage unit for buccal administration of a pharmacologically active agent
A simple and compact buccal dosage unit is provided for administering a pharmacologically active agent to a mammalian individual. The buccal dosage unit comprises the active agent to be...
|
|
|
6228864 |
Administration of 5-HT receptor agonists and antagonists, to treat premature ejaculation
A method is provided for delaying the onset of ejaculation in an individual. The method preferably involves administration of an antidepressant drug, a serotonin agonist or antagonist, an...
|
|
|
6221021 |
Method and apparatus for penile hemodynamic stimulation, monitoring, and drug delivery acceleration
The present invention is directed toward a method and apparatus for stimulating and/or monitoring hemodynamic activity, such as blood flow, in a penis. The method of the present invention comprises...
|
|
|
6200983 |
Dosage forms containing apomorphine for ameliorating male erectile dysfunction
Psychogenic impotence or erectile dysfunction can be identified in psychogenic male patients and can be ameliorated, without substantial undesirable side effects, by sublingual administration of...
|
|
|
6156753 |
Local administration of type III phosphodiesterase inhibitors for the treatment of erectile dysfunction
A method is provided for treating erectile dysfunction, e.g., vasculogenic erectile dysfunction such as vasculogenic impotence. The method involves the administration of a Type III...
|
|
|
6127363 |
Local administration of Type IV phosphodiesterase inhibitors for the treatment of erectile dysfunction
A method is provided for treating erectile dysfunction, e.g., vasculogenic erectile dysfunction such as vasculogenic impotence. The method involves the administration of a Type IV phosphodiesterase...
|
|
|
6124461 |
Compounds, compositions, and methods for treating erectile dysfunction
Vasoactive compounds are described for the treatment of erectile dysfunction and impotence. The compounds are reaction products of an anionic or negatively charged vasoactive or erection-inducing...
|
|
|
6121276 |
Apomorphine-containing dosage forms for ameliorating male erectile dysfunction
Psychogenic impotence can be ameliorated without substantial undesirable side effects by administration of apomorphine and an antiemetic agent in an amount sufficient to substantially reduce nausea...
|
|
|
6103765 |
Methods for treating male erectile dysfunction
Administration of a pharmaceutical composition comprising: (a) a vasodilator; and (b) a 15-hydroxyprostaglandindehydrogenase inhibitor is effective for the treatment of male erectile...
|
|
|
EP1005336A1 |
IMPROVED METHODS AND COMPOSITIONS FOR TREATING MALE ERECTILE DYSFUNCTION
Abstract not available for EP1005336 Abstract of corresponding document: US6414027 Administration of a pharmaceutical composition in the form of a suppository comprising:(a) a prostaglandin...
|
|
|
6037360 |
Administration of 5-HT.sub.3 receptor antagonists to treat premature ejaculation
A method is provided for delaying the onset of ejaculation in an individual. The method involves administration of a 5-HT 3 receptor antagonist within the context of an effective dosing regimen....
|
|
|
6037346 |
Local administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction
A method is provided for treating erectile dysfunction in a mammalian male individual. The method involves the local administration of a phosphodiesterase inhibitor or a pharmaceutically acceptable...
|
|
|
6031005 |
Composition and method for treating Peyronie's disease and related connective tissue disorders
The invention is of a topical medicament and associated methodology for use thereof, such that Peyronie's disease may be effectively, cost effectively, and painlessly treated. The primary active...
|
|
|
5994363 |
Amelioration of apomorphine adverse effects
Symptoms of Parkinson's disease and psychogenic male erectile dysfunction (MED) can be ameliorated through the use of apomorphine. The adverse side effects of apomorphine administration, such as...
|
|
|
5985889 |
Dosage forms and method for ameliorating male erectile dysfunction
Psychogenic impotence or erectile dysfunction can be identified in psychogenic male patients and can be ameliorated, without substantial undesirable side effects, by sublingual administration of...
|
|
|
5981593 |
Prostaglandin E2 treatment of impotence
The present invention relates to the treatment of impotence, and, more particular, to devices for the delivery of a clinicially effective amount of prostaglandin PGE 2 through the urethral mucosa...
|
|
|
5980972 |
Method of applying drug-release coatings
The invention is directed to a method of applying drug-release coatings whereby a polymer can be dissolved in a first solvent (solvent A) to form a polymer system and a drug can be dissolved or...
|
|
|
5971962 |
Skin button
A skin button comprising a cylindrical core component secured in the subcutaneous tissue of the living body as passing through the tissue, the core component has thorough holes which pass through...
|
|
|
5962528 |
Prostaglandin E.sub.2 /F.sub.2α combination for treating impotence
Disclosed herein is method of treating and a composition for treating erectile dysfunction in a male patient by administering to the patient a unit dose of a formulation comprising an erectile...
|
|
|
5952361 |
Compositions
The present invention involves the novel use of various classes of drugs, such as H 2 and H 3 agonists, as erectogenic agents in the treatment of male and female sexual dysfunction.
|
|
|
5947901 |
Method for hemodynamic stimulation and monitoring
The present invention is directed toward a method for stimulating and/or monitoring hemodynamic activity, such as blood flow, in a penis. The method of the present invention comprises the coupling...
|
|
|
5942545 |
Composition and method for treating penile erectile dysfunction
A composition for the topical transdermal administration to the penis is based on prostaglandin E 1 . The composition is non-irritating and effective for relieving erectile impotence or other...
|